Fei Shan
Impact in
- Gastroenterology top 1%
- Gastrointestinal Tumor Research and Treatment
-
- Gastric Cancer Management and Outcomes
- Metastasis and carcinoma case studies
Papers in
-
- Gastrointestinal Tumor Research and Treatment 42
-
- Gastric Cancer Management and Outcomes 80
- Metastasis and carcinoma case studies 44
Fei Shan
100 papers receiving 1.6k citations
Hit Papers
Peers
Comparison fields: 5 of 105
- Gastroenterology 478
- Pulmonary and Respiratory Medicine 1.1k
- Surgery 622
- Oncology 355
- Radiology, Nuclear Medicine and Imaging 272
Countries citing papers authored by Fei Shan
This map shows the geographic impact of Fei Shan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fei Shan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fei Shan more than expected).
Fields of papers citing papers by Fei Shan
This network shows the impact of papers produced by Fei Shan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fei Shan. The network helps show where Fei Shan may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Fei Shan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 6 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 0 | |
| 7 | 2024 | 1 | |
| 8 | 2023 | 16 | |
| 9 | 2022 | 11 | |
| 10 | 2022 | 1 | |
| 11 | 2021 | 11 | |
| 12 | 2021 | 6 | |
| 13 | 2021 | 3 | |
| 14 | 2020 | 8 | |
| 15 | 2020 | 3 | |
| 16 | 2020 | 58 | |
| 17 | [Current status of diagnosis and treatment of early gastric cancer in China--Data from China Gastrointestinal Cancer Surgery Union]. | 2018 | 26 |
| 18 | 2018 | 30 | |
| 19 | 17. Phase II study of oxaliplatin plus S-1 as neoadjuvant chemotherapy for advanced gastric cancer: Response and safety results | 2012 | 1 |
| 20 | Updating advances and controversies on the multidisciplinary therapy of gastric cancer | 2012 | 3 |
About Fei Shan
Fei Shan is a scholar working on Gastroenterology, Pulmonary and Respiratory Medicine, Surgery, Oncology and Rehabilitation, having authored 104 papers that have together received 1.6k indexed citations. Recurring topics across this work include Gastric Cancer Management and Outcomes (80 papers), Metastasis and carcinoma case studies (44 papers), Gastrointestinal Tumor Research and Treatment (42 papers), Esophageal Cancer Research and Treatment (14 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (7 papers), Colorectal and Anal Carcinomas (7 papers), Esophageal and GI Pathology (7 papers) and Intraperitoneal and Appendiceal Malignancies (5 papers). The work is most often cited by research in Gastroenterology (478 citations), Pulmonary and Respiratory Medicine (1.1k citations), Surgery (622 citations), Oncology (355 citations) and Radiology, Nuclear Medicine and Imaging (272 citations). Fei Shan has collaborated with scholars based in China, Ethiopia and United States. Frequent co-authors include Jiafu Ji, Ziyu Li, Shuangxi Li, Xiangji Ying, Zhaode Bu, Lianhai Zhang, Yinkui Wang, Yan Zhang, Yongning Jia and Aiwen Wu. Their work appears in journals such as BMC Cancer, World Journal of Surgical Oncology, European Journal of Surgical Oncology, Gastric Cancer and Annals of Surgical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.